Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506415
Status:
COMPLETED
Last Update Posted:
2012-09-19
First Post:
2007-07-20
Brief Title:
Comparative Efficacy Safety and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimers Disease AD Showing Cognitive Decline
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CENA713D2340
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None